Can severe hyperglycemia, such as in hyperosmolar hyperglycemic state or diabetic ketoacidosis, precipitate seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Hyperglycemia Cause Seizures?

Yes, severe hyperglycemia can cause seizures, particularly in the context of hyperosmolar hyperglycemic state (HHS), though this is less commonly recognized than seizures from hypoglycemia.

Mechanism and Clinical Context

Hyperglycemia-induced seizures occur primarily through hyperosmolarity rather than the glucose elevation itself. When serum osmolality exceeds 320 mOsm/kg—the diagnostic threshold for HHS—neuronal dysfunction can manifest as altered mental status ranging from confusion to coma, and in some cases, seizures 1.

The pathophysiology involves:

  • Severe dehydration from osmotic diuresis
  • Electrolyte shifts across neuronal membranes
  • Increased extracellular osmolality causing cellular dysfunction
  • Direct metabolic stress on brain tissue

When to Suspect Hyperglycemia as the Seizure Etiology

Look for these specific clinical features:

  • Glucose ≥600 mg/dL (HHS threshold) 1
  • Serum osmolality ≥320 mOsm/kg (calculated as: 2[Na] + glucose/18) 1
  • Profound dehydration with poor skin turgor, hypotension, tachycardia
  • Altered mental status preceding or accompanying seizures—stupor/coma is the expected presentation in HHS 1
  • Gradual onset over days to weeks (unlike DKA which evolves over ~24 hours) 1
  • Absence of significant ketosis (small ketones only in HHS vs. positive in DKA) 1

Seizure Characteristics in Hyperglycemic States

Recent case reports reveal important patterns:

Focal seizures are more common than generalized seizures in HHS 2, 3, 4. Patients may present with:

  • Focal motor seizures (e.g., limb twitching) 4
  • Non-convulsive status epilepticus 2
  • Visual field defects (homonymous hemianopia) 5
  • MRI changes mimicking acute stroke 3

Critical pitfall: Patients with HHS who remain unresponsive despite metabolic correction may be having subclinical epileptiform activity requiring EEG monitoring 2. Failure to recognize this can lead to permanent hippocampal damage and chronic epilepsy 2.

DKA vs. HHS: Different Seizure Risks

While both can cause seizures, the presentations differ:

HHS (more likely to cause seizures):

  • Extreme hyperglycemia (≥600 mg/dL)
  • Marked hyperosmolarity (≥320 mOsm/kg)
  • Focal neurological deficits common
  • Higher mortality (15%) 1

DKA (seizures less common but reported):

  • Moderate hyperglycemia (≥250 mg/dL)
  • Variable osmolality
  • Generalized seizures when they occur 5, 6
  • Lower mortality (5%) 1

Overlap syndrome (one-third of cases) carries the highest risk, combining features of both conditions with increased complications including seizures 7.

Management Priorities

When seizures occur in hyperglycemic crisis:

  1. Correct the metabolic derangement first—seizures typically resolve with normalization of glucose and osmolality 5, 4

  2. Fluid resuscitation is paramount:

    • 0.9% saline at 15-20 mL/kg/h initially 8
    • Target osmolality reduction <3 mOsm/kg/h to avoid cerebral edema 9
  3. Insulin therapy:

    • Continuous IV infusion 0.05-0.1 units/kg/h 8, 9
    • Do NOT aggressively lower glucose—this increases seizure risk from rapid osmotic shifts
  4. Seizure management:

    • Standard antiepileptic drugs (phenobarbital, benzodiazepines) for acute control 6
    • Most seizures are transient and resolve with metabolic correction 5
    • Consider EEG if mental status doesn't improve despite metabolic normalization 2
  5. Monitor for complications:

    • Severe hypokalaemia occurs in ~50% during treatment and increases mortality 8
    • Cerebral edema from overly rapid correction
    • Thromboembolism risk is elevated 7

Key Clinical Pearls

  • Elderly patients and nursing home residents are at highest risk for HHS with neurological complications 1, 4
  • MRI changes in HHS can mimic acute stroke with restricted diffusion, but these are typically reversible with treatment 3
  • Seizures may be the presenting symptom of previously undiagnosed diabetes 4, 6
  • Mortality remains high (15% in HHS) especially with coma, hypotension, and extremes of age 1

Bottom line: Any patient presenting with new-onset seizures and altered mental status requires immediate glucose and electrolyte assessment. If glucose >600 mg/dL with calculated osmolality >320 mOsm/kg, treat the hyperglycemic crisis as the primary cause while providing seizure control, recognizing that neurological symptoms should resolve with metabolic correction.

Related Questions

What are the differences in the management of hyperosmolar hyperglycemic state (HHS) and diabetic ketoacidosis (DKA)?
Is bowel rest (nil by mouth) a standard component of management for a hyperglycemic crisis such as diabetic ketoacidosis or hyperosmolar hyperglycemic state?
In an 84-year-old female with a blood glucose of 699 mg/dL, bicarbonate 19 mmol/L, anion gap 15, venous pH 7.40, serum osmolality 301 mOsm/kg, and beta‑hydroxybutyrate 0.33 mmol/L, does she meet criteria for hyperosmolar hyperglycemic state?
What is an emergency checklist for diagnosing and managing hyperosmolar hyperglycemic state, including glucose and serum osmolarity criteria, fluid resuscitation, potassium replacement, insulin titration, monitoring frequency, and precautions according to British Diabetes Society guidelines?
How should I manage a diabetic patient with an insulin pump who presents with diabetic ketoacidosis or hyperosmolar hyperglycemic state?
What medications are recommended to treat compulsive picking and pulling behaviors in an older adult with vascular dementia?
When is it appropriate to combine ceftriaxone (third‑generation cephalosporin) with levofloxacin (fluoroquinolone), and what are the recommended dosing, duration, and safety considerations?
What is the recommended management for a breakthrough seizure in a patient taking levetiracetam?
What is the appropriate dosing and titration schedule of oxcarbazepine for treating vestibular paroxysmia, including considerations for elderly patients or those with renal impairment?
How should renal cysts and gallbladder calculi be managed in an 85‑year‑old patient?
What are the benefits of escitalopram on neuronal plasticity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.